Steroid overprescribing in primary care is a persistent problem — and long referral wait times are a big reason why. Experts say real-time communication between primary care physicians and rheumatologists, along with targeted medical education, could dramatically reduce unnecessary glucocorticoid use. Better collaboration isn't just good practice — it could protect patients from serious long-term side effects.
Glucocorticoids are a go-to fix for suspected rheumatologic conditions, offering fast symptom relief — but their long-term use carries serious risks. The problem? Patients are often stuck on steroids for months while waiting to see a rheumatologist, with one Canadian study finding a median 66-day wait from referral to specialist assessment, and a European study clocking the gap from rheumatoid arthritis symptom onset to rheumatologist evaluation at 24 weeks. That delay makes steroids hard to stop — and easy to overuse.
Experts are calling for a cultural shift: instead of submitting a referral and waiting, primary care physicians should build direct, informal relationships with rheumatologists they can consult in real time. Electronic consultation platforms have already shown promise, with roughly 40% of e-consults resolved without an in-person visit. Continuing medical education (CME) is another lever — a 2025 study found a 1-hour online course paired with personalized prescribing feedback led to nearly 50% fewer inappropriate corticosteroid injections.
Key Takeaways:
Why it matters: Steroid overuse isn't just a prescribing habit — it's a systems problem. Fixing it requires smarter collaboration, faster specialist access, and better education, all of which can meaningfully reduce patient harm.
